Early readmission in patients hospitalized for ulcerative colitis: incidence and risk factors

被引:25
|
作者
Tinsley, Andrew [1 ]
Naymagon, Steven [2 ]
Mathers, Bradley [3 ]
Kingsley, Michael [2 ]
Sands, Bruce E. [2 ]
Ullman, Thomas A. [2 ]
机构
[1] Penn State Hershey Med Ctr, Div Gastroenterol & Hepatol, Hershey, PA 17033 USA
[2] Mt Sinai Sch Med, Div Internal Med, Dr Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA
[3] Penn State Hershey Med Ctr, Hershey, PA 17033 USA
关键词
30-day readmission; 90-day readmission; inflammatory bowel disease; risk factors; ulcerative colitis; INFLAMMATORY-BOWEL-DISEASE; HEALTH-CARE; INFLIXIMAB; THERAPY; REHOSPITALIZATION; CYCLOSPORINE; PREDICTORS;
D O I
10.3109/00365521.2015.1020862
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective. Early readmission rates are becoming an integral measure of the quality of care for hospitalized patients with chronic diseases. The incidence and predictors of early readmission in patients with inflammatory bowel disease (IBD) are uncertain. Risk factors for readmission over the first few weeks may differ from those that influence re-hospitalization at later time points. We examined the incidence and predictors of both 30-day and 90-day readmissions among ulcerative colitis (UC) patients. Materials and methods. A retrospective, cohort study was performed including all severe UC patients admitted to a tertiary-care hospital between January 2007 and December 2011. All-cause readmissions to the medical or surgical service within 30 and 90 days were recorded to allow the calculation of early readmission rates. We used multiple logistic regression to analyze demographic, hospital-related, general medical and IBD-specific factors as potential risk factors for readmission. Results. There were a total of 229 patients discharged following hospitalization for severe UC. The 30-and 90-day readmission rates were 11.7% and 20.5%, respectively. Forty-seven percent of early readmissions were for colectomy. In the 30-day analysis, only the presence of extensive colitis (odds ratio 3.59; 95% confidence interval [CI] 1.41-9.13) compared with left-sided disease was independently associated with readmission. Extensive colitis (3.09, 95% CI 1.33-7.08), albumin on admission (0.56, 0.31-0.99) and being admitted to a housestaff service (2.87, 95% CI 1.14-6.54), were independent predictors of readmission at 90 days. Conclusions. Early readmission is common in IBD. Independent risk factors for early readmission included extensive colitis, admission albumin, and being admitted to a housestaff service.
引用
收藏
页码:1103 / 1109
页数:7
相关论文
共 50 条
  • [21] Risk factors for arthropathy in patients with ulcerative colitis after total colectomy
    Noda, Kentaro
    Okita, Yoshiki
    Mizutani, Yuki
    Sugitani, Naohiro
    Suzuki, Yasuo
    Kusunoki, Masato
    Nakajima, Ayako
    MODERN RHEUMATOLOGY, 2021, 31 (02) : 468 - 473
  • [22] Prevalence and risk factors of gallstone disease in Korean patients with ulcerative colitis
    Nam, Kwangwoo
    Lee, Jae Yong
    Park, Sang Hyoung
    Hwang, Ha Won
    Lee, Ho-Su
    Oh, Kyunghwan
    Hong, Hee Seung
    Kim, Kyuwon
    Park, Jin Hwa
    Hong, Seung Wook
    Hwang, Sung Wook
    Yang, Dong-Hoon
    Ye, Byong Duk
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Yang, Suk-Kyun
    INTESTINAL RESEARCH, 2024,
  • [23] Risk Factors for Nephrotoxicity due to Tacrolimus Therapy for Ulcerative Colitis
    Nakata, Satoshi
    Kakimoto, Kazuki
    Numa, Keijiro
    Kinoshita, Naohiko
    Kawasaki, Yuka
    Tatsumi, Yoshihiro
    Tawa, Hideki
    Koshiba, Ryoji
    Hirata, Yuki
    Ota, Kazuhiro
    Sakiyama, Naokuni
    Kojima, Yuichi
    Nishikawa, Hiroki
    Inoue, Takuya
    Takeuchi, Toshihisa
    Fukunishi, Shinya
    Miyazaki, Takako
    Nakamura, Shiro
    Higuchi, Kazuhide
    DIGESTION, 2022, 103 (05) : 339 - 346
  • [24] Cyclosporine is Safe and Effective in Patients With Severe Ulcerative Colitis
    Cheifetz, Adam S.
    Stern, Joshua
    Garud, Sagar
    Goldstein, Eric
    Malter, Lisa
    Moss, Alan C.
    Present, Daniel H.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2011, 45 (02) : 107 - 112
  • [25] Treatment of Severe Ulcerative Colitis: Differences in Elderly Patients?
    Vavricka, Stephan R.
    Rogler, Gerhard
    DIGESTIVE DISEASES, 2009, 27 (03) : 315 - 321
  • [26] Optimizing individualized management of patients with ulcerative colitis: Identification of risk factors predicting ulcerative colitis-associated neoplasia
    Jiang, Wenyu
    Lu, Meijiao
    Zhang, Li
    Xu, Chenjing
    Wang, Ruohan
    Xu, Ying
    Tang, Wen
    Zhang, Hongjie
    MEDICINE, 2023, 102 (32) : E34729
  • [27] Risk factors for proximal disease extension and colectomy in left-sided ulcerative colitis
    Sahami, S.
    Konte, K.
    Buskens, C. J.
    Tanis, P. J.
    Lowenberg, M.
    Ponsioen, C. J.
    van den Brink, G. R.
    Bemelman, W. A.
    D'Haens, G. R.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2017, 5 (04) : 554 - 562
  • [28] Risk factors and clinical implication of superimposed Campylobacter jejuni infection in patients with underlying ulcerative colitis
    Arora, Zubin
    Mukewar, Saurabh
    Wu, Xianrui
    Shen, Bo
    GASTROENTEROLOGY REPORT, 2016, 4 (04): : 287 - 292
  • [29] The outcomes and risk factors of early readmission in patients with intestinal Beh‡et's disease
    Park, Yong Eun
    Cheon, Jae Hee
    Park, Yehyun
    Park, Soo Jung
    Kim, Tae Il
    Kim, Won Ho
    CLINICAL RHEUMATOLOGY, 2018, 37 (07) : 1913 - 1920
  • [30] Validation of the Crohn's and Ulcerative Colitis questionnaire in patients with acute severe ulcerative colitis
    Hutchings, Hayley A.
    Alrubiay, Laith
    Watkins, Alan
    Cheung, W-Y
    Seagrove, Anne C.
    Williams, John G.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2017, 5 (04) : 571 - 578